Evidence map›Paper›PMID 37324024›Full record

ArticleFrontiers in oncology2023

Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022.

Jiahua Liu, Junnan Ma, Jiarong Zhang, Chengming Li, Bowen Yu, Hyok Chol Choe, Kaiyue Ding, Liu Zhang, Lin Zhang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jiahua LiuInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Junnan MaInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Jiarong ZhangInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Chengming LiInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Bowen YuInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Hyok Chol ChoeInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Kaiyue DingInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Liu ZhangInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Lin ZhangInstitute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1173863.].

Indexed as

bevacizumabbibliometricCitespacedrug resistanceovarian cancerPARP inhibitorsVosviewer

Identifiers

PMID37324024
PMCPMC10264800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.